Plasma biomarkers of brain injury in COVID-19 patients with neurological symptoms

Serum glial fibrillary acidic protein is a body fluid biomarker: A valuable prognostic for neurological disease – A systematic review

(2022) Luana Heimfarth et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: A meta-analysis

(2022) Lavienraj Premraj et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Neurological infection with SARS-CoV-2 — the story so far

(2021) Tom Solomon   Nature Reviews Neurology

Blood neurofilament light concentration at admittance: a potential prognostic marker in COVID-19

(2021) Anne Hege Aamodt et al.   JOURNAL OF NEUROLOGY

Blood neurofilament light chain and total tau levels at admission predict death in COVID-19 patients

(2021) Rebecca De Lorenzo et al.   JOURNAL OF NEUROLOGY

Soluble receptor for advanced glycation end products (sRAGE) as a biomarker of COVID-19 disease severity and indicator of the need for mechanical ventilation, ARDS and mortality

(2021) Adeline Lim et al.   Annals of Intensive Care

SARS-CoV-2 targets glial cells in human cortical organoids

(2021) Courtney L. McMahon et al.   Stem Cell Reports

Neurochemical signs of astrocytic and neuronal injury in acute COVID-19 normalizes during long-term follow-up

(2021) Nelly Kanberg et al.   EBioMedicine

Brain injury, endothelial injury and inflammatory markers are elevated and express sex-specific alterations after COVID-19

(2021) Jude Savarraj et al.   Journal of Neuroinflammation

Neurological Manifestations of COVID‐19: A review

(2020) Abigail Whittaker et al.   ACTA NEUROLOGICA SCANDINAVICA

A first case of meningitis/encephalitis associated with SARS-Coronavirus-2

(2020) Takeshi Moriguchi et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China

(2020) Ling Mao et al.   JAMA Neurology

Neurological manifestations of COVID-19 and other coronavirus infections: A systematic review

(2020) V. Montalvan et al.   CLINICAL NEUROLOGY AND NEUROSURGERY

Central nervous system manifestations of COVID-19: A systematic review

(2020) Ali A. Asadi-Pooya et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Neurological associations of COVID-19

(2020) Mark A Ellul et al.   LANCET NEUROLOGY

Neurochemical evidence of astrocytic and neuronal injury commonly found in COVID-19

(2020) Nelly Kanberg et al.   NEUROLOGY

Cytokine release syndrome‐associated encephalopathy in patients with COVID‐19

(2020) P. Perrin et al.   EUROPEAN JOURNAL OF NEUROLOGY

Upper respiratory tract levels of SARS-CoV-2 RNA and duration of viral RNA shedding do not differ between patients with mild and severe/critical COVID-19

(2020) Aylin Yilmaz et al.   JOURNAL OF INFECTIOUS DISEASES

The receptor for advanced glycation end product (RAGE) pathway in COVID-19

(2020) Demet Yalcin Kehribar et al.   BIOMARKERS

Biomarkers for central nervous system injury in cerebrospinal fluid are elevated in COVID‐19 and associated with neurological symptoms and disease severity

(2020) Johan Virhammar et al.   EUROPEAN JOURNAL OF NEUROLOGY

Cerebrospinal fluid findings in neurological diseases associated with COVID-19 and insights into mechanisms of disease development

(2020) Otávio Melo Espíndola et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

The S1 protein of SARS-CoV-2 crosses the blood–brain barrier in mice

(2020) Elizabeth M. Rhea et al.   NATURE NEUROSCIENCE

The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood–brain barrier

(2020) Tetyana P. Buzhdygan et al.   NEUROBIOLOGY OF DISEASE

Looking for novel, brain-derived, peripheral biomarkers of neurological disorders

(2018) Natalia Chmielewska et al.   Neurologia i Neurochirurgia Polska

The S100B story: From biomarker to active factor in neural injury

(2018) Fabrizio Michetti et al.   JOURNAL OF NEUROCHEMISTRY

Reactive Astrocytes: Production, Function, and Therapeutic Potential

(2017) Shane A. Liddelow et al.   IMMUNITY

A review of the clinical utility of serum S100B protein levels in the assessment of traumatic brain injury

(2016) Eric Peter Thelin et al.   ACTA NEUROCHIRURGICA

Fluid biomarkers for mild traumatic brain injury and related conditions

(2016) Henrik Zetterberg et al.   Nature Reviews Neurology

S100B as a glial cell marker in diabetic peripheral neuropathy

(2013) Asuman Celikbilek et al.   NEUROSCIENCE LETTERS

Systemic markers of inflammation are independently associated with S100B concentration: results of an observational study in subjects with acute ischaemic stroke

(2010) Christopher Beer et al.   Journal of Neuroinflammation

Astroglial Proteins as Diagnostic Markers of Acute Intracerebral Hemorrhage—Pathophysiological Background and Clinical Findings

(2010) Robert Brunkhorst et al.   Translational Stroke Research